Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 - PubMed (original) (raw)

doi: 10.1038/ni1118. Epub 2004 Sep 7.

Shintaro Sato, Ken J Ishii, Cevayir Coban, Hiroaki Hemmi, Masahiro Yamamoto, Kenta Terai, Michiyuki Matsuda, Jun-ichiro Inoue, Satoshi Uematsu, Osamu Takeuchi, Shizuo Akira

Affiliations

• PMID: 15361868
• DOI: 10.1038/ni1118

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

Taro Kawai et al. Nat Immunol. 2004 Oct.

Abstract

Toll-like receptors (TLRs) are involved in the recognition of microbial pathogens. A subset of TLRs, TLR7, TLR8 and TLR9, induces antiviral responses by producing interferon-alpha (IFN-alpha). Production of IFN-alpha is dependent on the Toll-interleukin-1 receptor domain-containing adaptor MyD88. Here we show that MyD88 formed a complex with the transcription factor IRF7 but not with IRF3. The death domain of MyD88 interacted with an inhibitory domain of IRF7, and this interaction resulted in activation of the IFN-alpha-dependent promoters. Furthermore, the adaptor molecule TRAF6 also bound and activated IRF7. Ubiquitin ligase activity of TRAF6 was required for IRF7 activation. These results indicate that TLR-mediated IFN-alpha induction requires the formation of a complex consisting of MyD88, TRAF6 and IRF7 as well as TRAF6-dependent ubiquitination.

PubMed Disclaimer

Similar articles

• Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
  Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, Matsuda M, Coban C, Ishii KJ, Kawai T, Takeuchi O, Akira S. Uematsu S, et al. J Exp Med. 2005 Mar 21;201(6):915-23. doi: 10.1084/jem.20042372. Epub 2005 Mar 14. J Exp Med. 2005. PMID: 15767370 Free PMC article.
• Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.
  Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T. Honda K, et al. Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15416-21. doi: 10.1073/pnas.0406933101. Epub 2004 Oct 18. Proc Natl Acad Sci U S A. 2004. PMID: 15492225 Free PMC article.
• Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
  Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K, Fujimoto J. Seki E, et al. Hepatology. 2005 Mar;41(3):443-50. doi: 10.1002/hep.20603. Hepatology. 2005. PMID: 15723296
• Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.
  O'Neill LA, Dunne A, Edjeback M, Gray P, Jefferies C, Wietek C. O'Neill LA, et al. J Endotoxin Res. 2003;9(1):55-9. doi: 10.1179/096805103125001351. J Endotoxin Res. 2003. PMID: 12691620 Review.
• The immunobiology of the TLR9 subfamily.
  Wagner H. Wagner H. Trends Immunol. 2004 Jul;25(7):381-6. doi: 10.1016/j.it.2004.04.011. Trends Immunol. 2004. PMID: 15207506 Review. No abstract available.

Cited by

• In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.
  Kochs G, Anzaghe M, Kronhart S, Wagner V, Gogesch P, Scheu S, Lienenklaus S, Waibler Z. Kochs G, et al. J Virol. 2016 Sep 29;90(20):9330-7. doi: 10.1128/JVI.00744-16. Print 2016 Oct 15. J Virol. 2016. PMID: 27512061 Free PMC article.
• Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
  Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Katakura K, et al. J Clin Invest. 2005 Mar;115(3):695-702. doi: 10.1172/JCI22996. J Clin Invest. 2005. PMID: 15765149 Free PMC article.
• Tissue-specific positive feedback requirements for production of type I interferon following virus infection.
  Prakash A, Smith E, Lee CK, Levy DE. Prakash A, et al. J Biol Chem. 2005 May 13;280(19):18651-7. doi: 10.1074/jbc.M501289200. Epub 2005 Mar 14. J Biol Chem. 2005. PMID: 15767254 Free PMC article.
• Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing?
  Conrady CD, Drevets DA, Carr DJ. Conrady CD, et al. J Neuroimmunol. 2010 Mar 30;220(1-2):1-9. doi: 10.1016/j.jneuroim.2009.09.013. Epub 2009 Oct 9. J Neuroimmunol. 2010. PMID: 19819030 Free PMC article. Review.
• The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1.
  Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. Yan N, et al. Nat Immunol. 2010 Nov;11(11):1005-13. doi: 10.1038/ni.1941. Epub 2010 Sep 26. Nat Immunol. 2010. PMID: 20871604 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal